+530% Short Squeeze: How POM's Filings Revealed What Was About To Come (Forensic Filing Analysis)

By SNACS Trade ยท 2026-10-23T13:00:01.106701+00:00

POM ran +530% from $0.43 to $2.73 after a 6-K on October 19 ended its depositary receipt program. Here is the filing trail, the 2.58M float and the session math.

TLDR

image-1

What Drove POM's +530% Move?

The move came from a change in listing structure, not an offering, an FDA action or a contract. On October 19, POMDOCTOR LIMITED filed a 6-K, and a press release the same day was headlined 'POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq.' The run followed within two sessions.

POM is a China-based Healthcare company (Medical - Pharmaceuticals) listed on Nasdaq. It is a foreign private issuer, so it files 6-Ks where a domestic issuer would file 8-Ks. That matters for reading the paper trail. Material corporate actions show up in 6-Ks, and every filing in POM's 90-day window except one is a 6-K.

The press release does not give a conversion ratio between the depositary shares and the Class A Ordinary Shares, and the data here does not either. What the data does show is the result. A stock with a 2,580,000-share float, which had been trading 17,213 to 164,254 shares a day the week before, printed 48,813,210 shares on October 21.

The word 'short squeeze' in the title needs one caveat. Short interest was only 0.2%, so this was not a crowded short getting run over. It was a supply squeeze on a tiny float. Volume ran many times the available share count, and buy pressure pushed into a thin order book.

POM Filing Timeline: Every SEC Filing From July to October 2026

POM's 90-day filing record holds no registration statement and no pricing supplement. It is a run of 6-Ks plus one S-8, and the market-moving 6-Ks line up with dated news headlines. Here is the chronological record, using the dates the data provides.

Date Form / Event What It Is Possible Outcome
2026-07-28 S-8 Registers shares for an employee equity plan Plan shares can enter the float as awards vest. The share amount is not surfaced in the data. Low near-term risk, slow-drip supply
2026-08-27 6-K + press release 'Initiates U.S. Market Preparation and Unveils Expansion Strategy' Early signal that management was focused on the U.S. listing structure. No share issuance attached
2026-09-04 6-K Foreign issuer current report No pricing or offering language in the headline set. No direct dilution
2026-09-24 6-K Foreign issuer current report Part of a cluster of four 6-Ks in nine days (09-24, 09-29, 09-30, 10-02)
2026-09-29 6-K Foreign issuer current report Same cluster. Raised the filing cadence ahead of October
2026-09-30 6-K Foreign issuer current report Same cluster
2026-10-02 6-K Foreign issuer current report Same cluster
2026-10-09 6-K + press release 'Announces Receipt of Nasdaq Staff Delisting Determination' Listing-status risk is now on file. The next step in the listing process becomes the catalyst to track
2026-10-12 Press release 'Highlights the Shift from Reactive Treatment to Predictive Healthcare' Promotional headline. On October 13, the next session, POM closed at $0.75 (+36.1%) on 164,254 shares
2026-10-19 6-K + press release 'Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq' Changes the listing instrument. This preceded the 48,813,210-share session on October 21

Forensic read: in this window, the 6-Ks with headlines attached were the ones that moved the stock. The October 9 delisting determination and the October 19 depositary termination are two structural notices filed 10 days apart. A trader reading POM's SEC Filings had both on screen before the October 20 open at $0.43.

A dated filing chain like this one is easier to follow as a timeline:

image-2

What Each Filing Type Means for POM Shareholders

Each form in POM's record maps to a specific shareholder consequence. The form that matters most is one that is missing: POM has no shelf registration on file in the 90-day window.

The lack of a shelf is the key forensic point. Most squeezes covered on SNACS end with paper. We traced that pattern in The Paper Trail Behind TCRT's +512% Run and in MSGY's +560% reverse-split squeeze. On POM's filing record, no registered shares were waiting to be sold into the spike.

POM Share Structure: Float, Market Cap and Dilution Exposure

POM's structure is very small. It has a 2,580,000-share float, a $4,000,000 market cap, and a $11,200,000 enterprise value that sits well above the market cap. Short interest is 0.2% and institutional ownership is 0.4%, so almost all of the float trades in retail and market maker hands.

Metric Value Why It Matters
Float 2,580,000 Under 5M shares. Volume on October 21 was many multiples of this
Market cap $4,000,000 Micro-cap. Small dollar inflows move the price hard
Enterprise value $11,200,000 EV above market cap means debt is greater than cash by definition
Short interest 0.2% Not a crowded short. The squeeze was supply-driven
Institutional ownership 0.4% Very little sticky holder base
Filings (90 days) 12 11 6-Ks, 1 S-8

On dilution, the dilution data lists a completed historical offering for POM. A completed offering is capital already raised, not a current overhang. The data does not surface an active shelf, ATM, warrant or convertible facility for POM. Read that as a lack of registered overhang, not as proof that dilution is impossible. A company can file an F-3 or an F-1 at any time.

For scale, the wider market carries ~6,200 active warrant facilities, ~3,300 active shelves, ~2,200 active ATM programs, ~1,600 active convertible notes, ~900 active convertible preferred facilities, ~700 active S-1 offerings and ~600 active equity lines. Most small-cap runners trade against at least one of those. On the filings in the data, POM did not.

The data does not include a cash balance or runway figure for POM. The EV-over-market-cap gap is the balance sheet number you have, and it means the cash position is the first thing to check in the SEC research Dilution Snapshot before you treat the listing change as the end of the story.

POM Price Action: Session-by-Session Breakdown

POM moved from a quiet $0.60-$0.75 range to a $5.89 day high in two sessions, then gave back most of the after-hours spike the next day. The table below shows all three sessions for each day, using the bare Open/Close convention for the regular session.

Date Pre-Market Regular Session Open -> Close After-Hours Volume Change vs Prior Close
2026-10-13 $0.50 -> $0.50 $0.55 -> $0.75 $0.75 -> $0.75 164,254 +36.1%
2026-10-14 $0.69 -> $0.67 $0.66 -> $0.64 $0.52 -> $0.59 25,431 -2.3%
2026-10-15 - $0.63 -> $0.71 - 17,213 +13.1%
2026-10-16 - $0.65 -> $0.61 $0.63 -> $0.64 25,661 -6.6%
2026-10-19 - $0.64 -> $0.60 $0.53 -> $0.60 118,539 -6.6%
2026-10-20 - $0.43 -> $0.69 $0.66 -> $0.64 57,497 +59.8%
2026-10-21 $3.55 -> $0.95 $0.95 -> $2.00 $3.01 -> $2.90 48,813,210 +110.5%
2026-10-22 $2.92 -> $2.11 $2.11 -> $2.03 $2.03 -> $1.91 14,581,990 -3.8%

Last week (Oct 12-Oct 16) set the base. October 13 printed the only real volume, 164,254 shares, on a +36.1% close at $0.75. That came one session after the October 12 'predictive healthcare' release and two sessions after the October 9 delisting notice. The stock then drifted back to $0.61 by the October 16 close.

This week so far (Oct 19-Oct 23) is when the move happened:

The tape lesson: October 21's regular session closed at its high, but the after-hours session held the real extension, and the next pre-market gave it back. Anyone who chased after-hours strength above $2.90 was underwater at the $2.11 pre-market close on October 22.

What Was the Profit Potential on POM?

POM offered a large range of outcomes, from a full-MFE trade worth more than seven times the stake to a next-day chase that lost money. Using a $10,000 base:

Trade Entry -> Exit Return Dollar Result
Full move (verified) $0.43 (Oct 20) -> $2.73 (Oct 22) +530% +$53,000
5-day close-to-close $0.65 -> $2.03 +212% +$21,200
Oct 21 full-day MFE $0.69 low -> $5.89 high +753.6% +$75,360
Oct 21 regular session $0.95 open -> $2.00 close +110.5% +$11,050
Oct 22 regular session $2.11 open -> $2.03 close -3.8% -$380

The full-move trade returned $53,000. The more realistic version, taking the October 21 regular session from open to close, captured $11,050. Nobody prints the full $75,360 MFE. The low came at 9:35 AM ET and the high came after 6:30 PM ET, nine hours and two sessions apart. The October 22 line is the honest counterweight: the session after a 1378.5x volume day lost money from the open.

image-3

How POM Compares to This Week's Other Runners

POM led the five-session window ending October 22 by close-to-close gain. It was the one top runner whose catalyst was a listing-structure filing and not a contract or an unexplained spike. The 5-session window from Oct 16 to Oct 22 produced 29 runners of 50% or more against a 4-week baseline of ~8.0 per week, so POM was not running alone.

Ticker Move Volume Catalyst (Verified) Outcome
POM +211.5% ($0.65 -> $2.03) 48,813,210 max day 6-K: depositary termination (Oct 19) MFE +753.6% on Oct 21
XLAB +159.6% ($1.84 -> $4.79) 171,624,284 max day Not identified in available press releases Held the 5-day gain
SLN +115.1% ($9.10 -> $19.57) 71,967,248 max day Not identified in available press releases Two-session run
WORX MKT +90.7% (Oct 19) 126.0M 'SCWorx Announces New Agreement with Healthcare System' MFE +237.0%, after-hours close $3.32
AAME MKT +3.9% (Oct 19) 44.6M (506.0x average daily volume) Nasdaq Staff Delisting Determination (Oct 22) MFE +54.4%
RBNE MKT -76.2% (Oct 21) 150.5M (1829.0x average daily volume) No press releases or news found MFE +897.1%, close $0.24

Two comparisons stand out.

AAME is the delisting-notice mirror. Atlantic American received a Nasdaq Staff Delisting Determination tied to delayed periodic reports (press release, October 22), the same kind of notice POM received on October 9. AAME's October 19 session showed a +54.4% MFE but closed only +3.9%. A delisting notice on its own did not produce a POM-sized move. The structural follow-up filing did.

RBNE shows the downside. RBNE printed a +897.1% MFE on October 21, the same day as POM's run, with a pre-market high of $2.10, and then closed the regular session at $0.24 (-76.2%). Two stocks spiked on the same day and ended in very different places. RBNE had no catalyst in the available press releases. POM had a dated 6-K.

The macro backdrop made POM's move stand out more. The macro call is Risk-Off / Consolidation. The Russell 2000 (IWM) sat at $276.67, -9.3% from its 52-week high of $305.18, and the S&P 500 (SPY) closed at $763.96. In a defensive tape, structural float catalysts are among the few setups that run whatever the indexes do. We covered the same week from the sector-rotation angle in the Risk-Off weekly small-cap read.

The Opportunity and the Risk

The opportunity on POM was a float squeeze with no registered shares in front of it. The risk is everything the filings do not yet show. Both sides come straight from the paper trail.

The opportunity:

The risk:

How Could You Have Caught POM Before It Ran?

POM gave three dated signals before the move: a delisting notice on October 9, a volume spike on October 13 and the depositary termination 6-K on October 19. All three were visible a full session before the October 21 run.

  1. The October 9 delisting determination (6-K). This put POM on any listing-risk watchlist. Delisting-notice names with tiny floats tend to move on the next structural filing, in either direction.
  2. The October 13 volume tell. 164,254 shares and a +36.1% close came after days of 17,000-25,000 share sessions. That is unusual relative volume on a 2,580,000-share float. Market makers were probing the supply on the float a week before the move.
  3. The October 19 filing-day close. The termination 6-K hit and the stock closed red at $0.60 on 118,539 shares. A filing that changes the trading instrument, followed by a red close, is the setup. The market had not priced it yet.
  4. The October 20 open at $0.43. That was the lowest print of the move, on 57,497 shares. Anyone watching the filing had a full session at sub-$0.70 prices before the 48,813,210-share day.

This is the same discipline we used in Inside OLB's +291% Run. Read the filing on the day it posts, then watch whether the tape reacts. When the tape has not reacted yet, there is still time to act.

How to Play a Listing-Structure Squeeze

A listing-structure squeeze rewards traders who position on the filing and sell into extended-hours strength. It punishes traders who chase the next morning. This framework is drawn directly from POM's sessions, as education rather than advice.

Log these trades with session tags in the trading journal. AI Insights then shows whether your MFE capture comes from regular-session or extended-hours exits. On a stock like POM, that split decides the result.

How to Find These Setups on SNACS

The SNACS tools can find POM-type setups on the filing date instead of the spike date. The approach combines a filing filter, a float filter and a relative volume trigger.

In the SNACS scanner:

Click any ticker to open the ticker details page. The dilution risk panel shows active shelf, ATM and warrant facilities. The SEC Filings list shows whether an F-3 or 424B5 exists, and the news feed shows the headline that came with each 6-K. On POM, that one view would have shown the depositary termination headline and the lack of a shelf at the same time.

In SEC research: run the Dilution Snapshot to check active facility types, shares at risk and baby shelf status. Then ask the AI Chat a direct question, for example 'Has POM filed an F-3 or F-1 since October 19?' The Filing Browser lets you read the 6-K text inline.

In the AI Playbook Builder: build a playbook with three steps. Step one is a structural filing (6-K or 8-K) on a sub-5M float. Step two is a red or flat filing-day close. Step three is a relative volume trigger. Live matching puts a star on the ticker in the scanner when all three line up.

If you run your own AI agent, the Data API and MCP server send the same float, filing and dilution data to Claude, Cursor or a custom script, with the source filing attached to every number.

What to Watch Next on POM

The next filing matters more than the next candle. Watch POM's SEC Filings for three things: an F-3 or F-1 (dilution capacity), any 6-K that resolves the October 9 delisting determination, and any 6-K that gives details on the move to Class A Ordinary Shares.

On price, the levels from the data are the $2.00-$2.03 regular-session closes from October 21-22, the $2.90 after-hours close from October 21, and the $0.69 low from October 21. The broader tape is still Risk-Off / Consolidation, with the Nasdaq 100 (QQQ) at $704.47, -7.7% from its 52-week high. Keep position sizes tight on any continuation attempt.

Across the market, intraday-doubling setups this week stand at 27 against a 90-day weekly average of 45.1. There are fewer of these moves than usual, so the ones with a dated filing behind them are worth more of your attention.

FAQ

Why did POM stock go up 530%?

POM ran +530% from $0.43 on October 20 to $2.73 on October 22 after a 6-K filing on October 19 announced the termination of its depositary receipt program, with Class A Ordinary Shares to trade on Nasdaq. The stock has a 2,580,000-share float, and on October 21 it traded 48,813,210 shares, 1378.5x its average daily volume.

Was POM a short squeeze?

POM was a float squeeze more than a classic short squeeze, because short interest was only 0.2%. Volume ran many multiples of the 2,580,000-share float on October 21, and buy pressure pushed through a thin order book from $0.69 to $5.89.

Does POM have a shelf registration or active offering?

POM's 12 SEC filings in the last 90 days are 11 6-Ks and one S-8 (2026-07-28), with no F-3, S-3, F-1 or 424B5. The dilution data lists a completed historical offering, which is capital already raised and not a current overhang.

What does a 424B5 filing mean for a small-cap stock?

A 424B5 is a pricing supplement, and it means a shelf offering is live and shares are being sold. Over the past 3 days, 13 424B5 filings came from 11 unique tickers. A stock without a shelf on file cannot run that takedown until it files a registration statement.

What was the profit potential on POM on October 21?

POM's October 21 full-day MFE was +753.6%, from a $0.69 low to a $5.89 high, which is $75,360 on a $10,000 position. The regular session alone ran from a $0.95 open to a $2.00 close, +110.5%, or $11,050.

What are the risks of holding POM after the run?

POM's main risks are the Nasdaq Staff Delisting Determination filed on October 9, an enterprise value of $11,200,000 above its $4,000,000 market cap, and the chance of a future F-3 or F-1 registration. On October 22 the stock closed at $2.03 (-3.8%) and finished after-hours at $1.91.

How do I find stocks like POM before they run?

In the SNACS scanner, filter for floats under 5M shares, a 6-K or 8-K filing type and relative volume of 5x or more, then link the saved scan to a Dynamic Watchlist. Click any match to open the ticker details page and check the SEC Filings list and dilution panel before the volume arrives.

Start Free Trial

5 trading day free trial on Edge. Cancel anytime before your trial ends to avoid being charged.